Synaptics officer sells 8,833 shares in open-market trades
Synaptics Inc. officer Esther Song reported multiple open-market sales of company common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Synaptics Inc. officer Esther Song reported multiple open-market sales of company common stock. On May 28, 2026, she sold a total of 8,833 shares at prices generally between about $137 and $143 per share under a pre-arranged Rule 10b5-1 Trading Plan dated February 26, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,200 | $137.61 | $165K |
| Sale | Common Stock | 600 | $139.10 | $83K |
| Sale | Common Stock | 1,361 | $140.58 | $191K |
| Sale | Common Stock | 2,714 | $141.75 | $385K |
| Sale | Common Stock | 2,601 | $142.70 | $371K |
| Sale | Common Stock | 357 | $143.32 | $51K |
Footnotes (7)
- F1. The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.
- F2. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $137.32 to $138.02, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $138.67 to $139.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $139.96 to $140.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.97, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F6. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $142.19 to $143.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F7. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $143.25 to $143.38, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 Trading Plan regulatory
weighted average financial
open-market sale financial
non-derivative financial
net-sell financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Esther Song report for SYNAPTICS Inc (SYNA)?
How many separate sales did Esther Song make of SYNA stock on May 28, 2026?
Was Esther Song’s SYNA stock sale made under a Rule 10b5-1 trading plan?
What type of security did Esther Song sell in this SYNA Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.